CD8A and neoplasm: For instance, it has been demonstrated that purinergic nucleosides produced by tumor-educated MSCs isolated from human cervical cancer (CeCa) patients inhibit the proliferation, activation, and effector activities of CD8+ T lymphocytes (de Lourdes Mora-García et al., 2016).